DRREDDY's weekly performance was lackluster, with a return of -0.22% and a Sharpe Ratio of -0.03, indicating poor risk-adjusted returns. The stock's volatility was moderate at 24.23%, but its Max Drawdown of -2.14% suggests a relatively high risk profile. Compared to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. Overall, the stock's performance was disappointing and relatively risky this week.

[Volatility: 24.23%]